Trials / Unknown
UnknownNCT03830450
Biomarkers of Acute Kidney Injury in Cardiac Surgery
Biomarkers in Estimation for Risk of Acute Kidney Injury in Cardiac Surgery
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Nikola Bradic, MD · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Acute kidney injury (AKI) is the most common complication in patients after cardiac surgery. An usual estimation of risk for AKI is estimation of serum creatinine, which is unreliable indicator of AKI risk. Because of that, today different biomarkers are investigated to predict incidence for development AKI after cardiac surgery. This investigation will try to find potentially risk patients for developing AKI after cardiac surgery by using conventional markers (creatinine, glomerular filtration rate) in perioperative period comparing with two different biomarkers neutrophil gelatinase-associated lipocalin (NGAL) and growth differentiation factor 15 (GDF-15) which are proven markers in patients with increased risk for AKI development.
Conditions
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2019-02-05
- Last updated
- 2020-11-13
Source: ClinicalTrials.gov record NCT03830450. Inclusion in this directory is not an endorsement.